Associate Professor Yasin Kutlu is a medical oncologist and faculty member at the medical school, seeing patients at Medipol Mega University Hospital in Istanbul. The doctor specializes in the medicinal treatment of solid tumors and develops an individualized therapy plan considering the tumor type, disease stage, molecular characteristics, and the patient’s general condition.
During the consultation, the doctor reviews histological reports, imaging and laboratory results, and information about previous treatments. After evaluating the data, he discusses with the patient the possible sequence of drug therapy and the need for a joint decision with surgeons, radiation oncologists, radiologists, and other specialized professionals. The final treatment plan is determined individually.
The doctor graduated from Trakya University Faculty of Medicine in 2011. After mandatory public service, he specialized in internal medicine at Okmeydanı Training and Research Hospital. In 2020, ranking 10th in Turkey on the YDUS exam, he began an additional specialization in medical oncology at Medipol Mega and completed it in 2023. In 2025, he received the title of Associate Professor of Medical Oncology.
The doctor’s scientific activity is related to personalized cancer treatment and the search for factors influencing treatment effectiveness. He has researched HER2 loss after neoadjuvant breast cancer treatment, immuno- and chemoimmunotherapy for lung cancer, treatment of triple-negative breast cancer, the use of nivolumab in stomach and gastroesophageal junction tumors, and prognostic markers in prostate and colorectal cancer. The AVESIS university system lists 20 scientific articles, including publications in international peer-reviewed journals and multicenter studies by the Turkish Oncology Group.
To consult and receive treatment from Associate Professor Yasin Kutlu, please submit an application on the website. Experts Medical coordinating doctors will help you transfer medical documents, obtain a preliminary opinion, arrange an appointment date, and organize your trip to Turkey.
Associate Professor Yasin Kutlu’s scientific activity focuses on personalized drug treatment of solid tumors and the search for factors that predict treatment effectiveness.
His work is based on multicenter real-world clinical practice studies. He participates in projects of the Turkish Oncology Group (TOG) and coordinates two multicenter studies on the treatment of non-small cell lung cancer. He is the author of two chapters on the diagnosis and treatment of endocrine and hepatic complications of immunotherapy.
The AVESIS system presents 20 articles: 14 are indexed in SCI-E, SSCI, or AHCI, 17 in Scopus, and 4 in TRDizin. The works are published in Cancers, Current Problems in Cancer, Medicine, International Immunopharmacology, International Journal of Clinical Oncology, and other peer-reviewed journals.

Medipol Mega University Hospital is a multidisciplinary university complex in the Bağcılar district of Istanbul, operating since 2012. Its structure includes a specialized oncology hospital. According to Medipol, the complex brings together academic specialists from various fields and provides medical care 24/7.
Associate Professor Yasin Kutlu consults in the Department of Medical Oncology. Here, patients with breast, lung, stomach, intestinal, genitourinary, and gynecological cancers can receive consultation, evaluation of biopsy results, laboratory tests, and imaging, as well as an individualized drug treatment plan. If necessary, the clinical case is reviewed jointly with surgeons, radiation oncologists, radiologists, and other specialists.
The complex has 810 beds, 215 intensive care units, 358 outpatient clinics, and 25 operating rooms. The infrastructure allows for diagnosis, treatment, and follow-up in one medical center. The hospital has international JCI accreditation.
